http://www.lifesciadvisors.com/news/lifesci-advisors-initiates-coverage-of-chemgenex-pharmaceuticals/
"we believe that approval is highly likely and that OMAPRO will become the treatment of choice in this population, which we estimate will be near a $500MM opportunity in 2012"
[holding CXSOA options]